The intra‐individual stability of growth hormone (GH) biomarkers IGF‐I, P‐III‐NP, calculated GH‐2000 score in relation to growth hormone‐releasing hormone (GHRH) (Somatorelin) administration, menstrual cycle, and hematological parameters were investigated in four men and eight women, respectively. Moreover, the hematological parameters hemoglobin (Hb) and percentage of reticulocyte (RET%) were statistically analyzed in relation to the GH biomarker parameters for the GHRH administration study and the menstrual cycle study. Longitudinal monitoring of IGF‐I and/or GH‐2000 score proved to be a viable approach to detect the GHRH intake in men, as all four participants show values above individually calculated thresholds (calculated as mean ± 3SD from three baseline samples). The intra‐individual variation for IGF‐I, P‐III‐NP, and calculated GH‐2000 score in women, over two consecutive menstrual cycles, was investigated and established to be higher (coefficients variations [CVs] between 12% and 186%) than in men (CVs between 3% and 12%). The GHRH administration did not influence the hematological parameters. A strong positive correlation between Hb and IGF‐I (Rs = 0.73, p < 0.0001) and a borderline weak correlation between RET% and IGF‐I (Rs = 0.28, p = 0.054) were noticed in the women. No correlation for the P‐III‐NP and the hematological parameters was seen for the females in the menstrual cycle study. The results fortify previous studies that longitudinal monitoring of IGF‐I and/or GH‐2000 score may be a promising method to detect doping with GH and GH stimulating agents in men, whereas the large intra‐individual variation noted in women indicates that longitudinal monitoring of these biomarker may be harder to evaluate in women.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.